Quantum BioPharma Ltd. Interest Expense
Quantum BioPharma Ltd. (QNTM) reported Interest Expense of $9.34 thousand for the 12-month period ending 2024-12-31, per its 20-F/A filed 2025-03-31.
Financial Statements › Expense Statement › Interest Expense
ifrs-full:InterestExpense · last filed 2025-03-31
- Quantum BioPharma Ltd. interest expense for the quarter ending 2024-12-31 was -$21.80K, a 806.15% decline year-over-year.
- Quantum BioPharma Ltd. interest expense for the quarter ending 2024-09-30 was $10.37K, a 69.18% increase year-over-year.
- Quantum BioPharma Ltd. interest expense for the quarter ending 2023-12-31 was $3.09K.
- Quantum BioPharma Ltd. interest expense for the quarter ending 2023-09-30 was $6.13K.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month | Interest Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2024-12-31 | -$21.80K derived: 20-F/A 12 month − 6-K 9 month · filed 2025-03-31 | -$11.43K derived: sum of 2 quarters · filed 2025-03-31 | $9.34K 20-F/A · filed 2025-03-31 | ||
| 2024-09-30 | $10.37K derived: 6-K 9 month − 6-K/A 6 month · filed 2024-11-12 | $31.14K 6-K · filed 2024-11-12 | |||
| 2024-06-30 | $20.77K 6-K/A · filed 2024-08-19 | ||||
| 2023-12-31 | $3.09K derived: 20-F/A 12 month − 6-K 9 month · filed 2025-03-31 | $9.22K derived: sum of 2 quarters · filed 2025-03-31 | $24.29K 20-F/A · filed 2025-03-31 | ||
| 2023-09-30 | $6.13K derived: 6-K 9 month − 6-K/A 6 month · filed 2024-11-12 | $21.20K 6-K · filed 2024-11-12 | |||
| 2023-06-30 | $15.07K 6-K/A · filed 2024-08-19 | ||||
| 2022-12-31 | $63.41K 20-F/A · filed 2025-03-31 | $149.91K 20-F · filed 2023-03-31 | |||
| 2021-12-31 | $69.40K 20-F · filed 2024-04-02 |